E3 Ligase Ligand-Linker Conjugate, which is one part of Proteolysis Targeting Chimeric Molecules (PROTACs), incorporates a ligand for the E3 ubiquitin ligase and a linker.These conjugates can be used to create PROTACs that target proteins for ubiquitination and destruction after being coupled to the ligand for the target protein (for example, JQ1 for the BRD4 protein or Molibresib for the BET protein). Currently, a number of PROTACs that specifically target BET, the estrogen receptor (ER), the androgen receptor, etc. have been identified to demonstrate good biological activity.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V82409 | N-Ethylpropionamide-PEG1-Br | 1539080-27-7 | N-Ethylpropionamide-PEG1-Br is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V104986 | N-Me-Thalidomide-NH-C6-NH2 | 2375536-48-2 | N-Me-Thalidomide-NH-C6-NH2 is an E3 ligase ligand-adapter conjugate. |
![]() |
V82342 | Narlumosbart | 2646587-68-8 | Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor agonist/activator of nuclear factor-κB ligand (RANKL). |
![]() |
V82373 | NH2-PEG3 hydrochloride | 92505-84-5 | NH2-PEG3 HCl is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V82507 | NH2-PEG5-C1-Boc | 2231845-67-1 | NH2-PEG5-C1-Boc is a PROTAC (PROteolysis TArgeting Chimera) linker of the PEG category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V76688 | Nutlin-C1-amido-PEG4-C2-N3 (MDM2 Ligand-Linker Conjugates 1; E3 ligase Ligand-Linker Conjugates 48) | Nutlin-C1-amido-PEG4-C2-N3 is a synthetic E3 ligase (e.g. CRBN) ligand-linker conjugate containing a Nutlin 3-based MDM2 ligand and a 4-unit PEG linker. | |
![]() |
V104645 | OICR-8268-acrylic acid-amino-PEG9-amine | OICR-8268-acrylic acid-amino-PEG9-amine is an E3 ligase ligand-linker complex. | |
![]() |
V104895 | OTs-PEG3-NHCO-Thalidomide | 2716123-18-9 | OTs-PEG3-NHCO-Thalidomide is a linker of ubiquitin E3 ligase and PROTAC α-synuclein degrader 6 for neurodegenerative disease research. |
![]() |
V104277 | p62-ZZ Ligand-Linker Conjugate 1 | 2410081-73-9 | p62-ZZ ligand-adaptor conjugate 1 is a p62-ZZ domain ligand-adaptor conjugate. |
![]() |
V82473 | PCDBCO-PEG4-NHS ester | 2055025-02-8 | PC DBCO-PEG4-NHS ester is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V82370 | PEG2-Cl | 78925-46-9 | PEG2-Cl is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V82498 | PEG2-ethyl acetate | 154773-33-8 | PEG2-ethyl acetate is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category, may be utilized to prepare PROTAC protein degraders. |
![]() |
V82493 | Phthalimide-PEG3-C2-OTs | 382162-12-1 | Phthalimide-PEG3-C2-OTs (Compound 5) is a PROTAC (PROteolysis TArgeting Chimera) linker and belongs to the PEG (Polyethylene glycol) class. |
![]() |
V94657 | Piperidin-4-amine-C5-O-C1-Thalidomide | 3038591-71-5 | Piperidin-4-amine-C5-O-C1-thalidomide (Compound D4) is an E3 ligase ligand-linker conjugate that can be used to synthesize PRPTAC. |
![]() |
V51728 | Pom-8PEG | 2488761-03-9 | Pom-8PEG, a ligand (for E3 ligase)-linker conjugate, contains a cereblon (CRBN) ligand for E3 ubiquitin ligase and an 8-unit PEG linker. |
![]() |
V84833 | Pomalidomide 4'-alkylC2-azide | 2296708-61-5 | |
![]() |
V84678 | Pomalidomide 4'-alkylC3-acid | 2225940-47-4 | |
![]() |
V84836 | Pomalidomide 4'-alkylC3-azide | 2357108-05-3 | |
![]() |
V84641 | Pomalidomide 4'-alkylC4-acid | 2225940-48-5 | |
![]() |
V51305 | Pomalidomide 4'-PEG3-azide | 2271036-46-3 | Pomalidomide 4'-PEG3-azide is a synthetic ?E3 ligase ligand-linker conjugate, containing Pomalidomide-based cereblon ligand and 1 linker, which can be used for the synthesis of iRucaparib-TP3. |